Researchers have created mice that are 500 times more sensitive than usual to TNT. They could provide a cheap, fast way to find buried explosives.
When he learned in 1995 that he had Alzheimer’s disease, William Utermohlen, an American artist living in London, immediately began work on an ambitious series of self-portraits.
More in Biomedicine
For the first time, researchers report that monkeys can use brain implants to control a left and a right arm.
Dimension Therapeutics wants to develop a lifetime fix for hemophilia using gene therapy.
The way DNA strands contract when they come into contact with viruses could lead to cheap and simple pathogen detectors, say physicists.
The U.K. plans to sequence 100,000 National Health Service patients by 2017—in a bold push to be a genomic medicine leader.
Spark Therapeutics hopes to commercialize multiple gene-based treatments developed at the Children's Hospital of Philadelphia.
The newest cancer drugs cost over $100,000 for a year of treatment. There are fairer ways to set prices.
Today’s medicines can cost hundreds of thousands of dollars a year. The story of how two companies set prices for their costly new drugs suggests that the way we determine the value of such treatments will help decide the future of our health-care system.
Biotech startup Greenlight Biosciences has a cell-free approach to microbial chemical production.
Study suggests how brain technology could one day tap into thoughts.
Scientists use immune cells to smuggle molecules across the blood-brain barrier in the hopes of treating neurodegenerative diseases.